HPG
REGN icon

Harvest Portfolios Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Harvest Portfolios Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.2M Buy
104,616
+32,219
+45% +$21.9M 0.92% 39
2026
Q1 		$55.9M Sell
72,397
-9,351
-11% -$7.16M 0.92% 36
2025
Q4 		$63.1M Sell
81,748
-25,799
-24% -$17.5M 1.1% 27
2025
Q3 		$60.5M Buy
107,547
+8,547
+9% +$4.83M 1.12% 27
2025
Q2 		$52M Buy
99,000
+16,076
+19% +$8.97M 1.21% 33
2025
Q1 		$52.6M Buy
82,924
+11,555
+16% +$7.95M 1.55% 20
2024
Q4 		$50.8M Buy
71,369
+27,029
+61% +$22.7M 1.7% 23
2024
Q3 		$46.6M Sell
44,340
-7,046
-14% -$7.84M 1.55% 26
2024
Q2 		$54M Sell
51,386
-4,568
-8% -$4.43M 2.06% 11
2024
Q1 		$53.9M Sell
55,954
-5,047
-8% -$4.8M 2.1% 13
2023
Q4 		$53.6M Sell
61,001
-3,601
-6% -$2.97M 2.27% 13
2023
Q3 		$53.2M Sell
64,602
-4,659
-7% -$3.66M 2.51% 7
2023
Q2 		$49.8M Buy
69,261
+4,504
+7% +$3.47M 2.28% 15
2023
Q1 		$53.2M Buy
64,757
+5,294
+9% +$3.99M 2.61% 6
2022
Q4 		$42.9M Buy
+59,463
New +$43.9M 2.47% 17

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Harvest Portfolios Group's REGN Position: Q2 2026 in Review

Harvest Portfolios Group increased its Regeneron Pharmaceuticals (REGN) stake by 45% in Q2 2026, buying an estimated $21.9M and bringing the position to 104,616 shares worth $65.2M. The position accounts for 0.92% of the portfolio, ranked #39.

Harvest Portfolios Group first reported a position in REGN in Q4 2022 and has held it in 15 quarters since. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Harvest Portfolios Group held 104,616 shares of Regeneron Pharmaceuticals worth $65.2M as of Q2 2026.
  • Harvest Portfolios Group bought 32,219 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $21.9M.
  • Regeneron Pharmaceuticals made up 0.92% of Harvest Portfolios Group's portfolio in Q2 2026, its #39 holding.
  • Harvest Portfolios Group first reported a position in Regeneron Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Harvest Portfolios Group's 13F filing for Q2 2026, filed 13 Aug 2026.